Statins' Anti-Atherogenic Effects: Understanding the Role of Nitric Oxide and Hem Oxygenase-1

Strategic Insights -

Scientists in the United States have made significant progress in elucidating the pleiotropic effects of HMG-CoA inhibitors, also known as statins, which include anti-inflammatory, antioxidative, and immunomodulatory properties. A recent study, published in the British Journal of Pharmacology, sheds light on the role of nitric oxide, peroxynitrite, and hem oxygenase-1 in the anti-atherogenic effect of statins. The research, conducted by G. Heeba and colleagues at Ohio University, aimed to investigate the mechanisms behind statins' ability to reduce atherosclerosis and improve endothelial function.

Key Takeaways:

  • The pleiotropic effects of statins, including anti-inflammation, antioxidation, and immunomodulation, are not yet fully understood.
  • The study found that hypercholesterolemia decreased endothelial nitric oxide synthase (eNOS) expression by 31% and decreased nitric oxide (NO) levels, while increasing peroxynitrite (ONOO-) levels and nitroxidative stress.
  • The concentration ratio of [NO]/[ONOO-] decreased from 2.3 (normal) to 0.7 (atherosclerotic) indicating an increase of nitroxidative stress in atherosclerotic endothelium.
  • Statins, specifically atorvastatin and simvastatin, partially restored the [NO]/[ONOO-] balance and decreased malondialdehyde (MDA) and vessel wall thickness.
  • Promoters of eNOS and hem oxygenase-1 (HO-1), such as L-arginine and haemin, ameliorated the [NO]/[ONOO-] ratio, while their inhibitors had no effects.
  • The study suggests that statins' anti-atherosclerotic effects are mediated by HO-1/eNOS, restoring the [NO]/[ONOO-] imbalance and reducing lipid peroxidation.

Statistics:

  • eNOS expression decreased by 31% in hypercholesterolemia.
  • NO levels decreased by 46% in hypercholesterolemia.
  • ONOO- levels increased by 59% in hypercholesterolemia.
  • Statins restored the [NO]/[ONOO-] balance to 1.4 and 1.5 for atorvastatin and simvastatin, respectively.
  • MDA levels decreased by 34% in statin-treated atherosclerotic rabbits.

Sources:

  • Heeba, G., et al. (2009). Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1. British Journal of Pharmacology, 156(8), 1256-1266.
  • Biotech Week editors, staff, and other reports (2009). Statins' Anti-Atherogenic Effects: Understanding the Role of Nitric Oxide and Hem Oxygenase-1. Biotech Week.